1681 Objectives: Castleman disease (CD) is an uncommon, poorly understood
lymphoproliferative disorder with varying clinical manifestations. We aimed to compare the …

19 Objectives: To evaluate the FDG PET/CT findings of Castleman disease (CD), and to
compare with histologic subtypes. Methods: We retrospectively reviewed FDG PET/CT …

1614 Objectives Castleman's disease (CD) is an uncommon lymphoproliferative disease.
CD is usually classified into two distinct subtypes; unicentric and multicentric. The abjective …

Background Castleman disease (CD) is a rare lymphoproliferative disorder including
unicentric and multicentric forms which can further be divided into four histopathologic …

Objective Castleman disease (CD) is a rare group of lymphoproliferative disorders, which is
easily confused with lymphoma or other solid tumors. Hence, this study aimed to investigate …

Purpose Castleman disease (CD) is a benign lymphoproliferative disease, which usually
shows hypermetabolism on 18 F-FDG PET/CT. In this study, we investigated metabolic …

Castleman disease (CD) is a relatively rare lymphoproliferative disorder and the
pathophysiology of the subtypes are incompletely understood. Fluorine-18 …

Castleman disease (CD) is a rare lymphoproliferative disorder of unknown etiology that may
occur anywhere in the lymphatic system. Imaging plays an important role in detecting and …

1560 Objectives To assess the value of 18F-FDG PET/CT in the management of
Castleman's disease (CD), including clinical classification, chemotherapeutic response …

Objective To evaluate the imaging characteristics of 18 F-FDG PET/CT in patients with
Castleman's disease (CD). Methods Twelve patients (male 7, female 5, mean age …